Optimization of lipoplex formulations for intravenous gene delivery

Journal of Liposome Research

Volumn 7, Issue 2-3, 1997, Pages 143-159

  Thierry, Alain R ^a  

^a Biovector Therapeutics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; GENE THERAPY; GENETIC TRANSFECTION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSMISSION ELECTRON MICROSCOPY;

EID: 16944363923     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109709035492     Document Type: Review

References (14)

1. Thierry, A.R., Rabinovich P., Peng B., Mahan L.C., Bryant J.L., and Gallo R.C. 1997. Characterization of liposome-mediated gene delivery: Expression, stability and pharmacokinetics of plasmid DNA. Gene Therapy, 4:226-237.
2. Sedelnikova, O.A., Thierry A.R., Neuman R.D., and Panyutin I.G. 1997. The radiotoxicity of iodine-125 labeled oligodeoxynucleotides in mammalian cells. Nuclear Med., in press.
3. Thierry, A.R., Lunardi-Iskandar, Y., Bryant, J.L., Rabinovich, P., Gallo, R.C. and Mahan, L.C. 1995. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice. Proc.Natl.Acad.Sci 92:9742-9746.
4. Aksentijevich, I., Pastan, I., Lunardi-Iskandar, Y., Gallo, R.C., Gottesman, M.M. and Thierry, A.R. 1996. In vitro and in vivo liposome-mediated gene transfer leads to human MDR-1 expression in mouse bone marrow progenitor cells. Human Gene Ther. 7:1111-1122.
5. Baudard, M., Flotte, T.C., Aran, A., Thierry, A.R., Pastan, I. and Gottesman, M.M. 1996. Expression of human multidrug resistance and gluco-cerebrosidase cDNAs from Adeno-Associated vectors: Efficient promoter activity of AAV sequences and in vivo delivery via liposomes. Human Gene Ther. 7:1309-1322.
6. Felgner, P.L., Barenholz, Y., Behr, J.P., Cheng, S.H., Cullis, P., Huang, L., Jessee, J.A., Seymour, L., Szoka, F., Thierry, A.R., Wagner, E., and Wu, G. 1997. Nomenclature for synthetic gene delivery systems. Hum.Gene Ther., 8:511-512.
7. Behr JP. 1986. DNA strongly binds to micelles and vesicles containing lipolyamines or lipointercalants. Tetrahedron Lett. 27:5861.
8. Behr, J.P., Demeneix, B., Loeffler, J.P., and Perez-Mutul, J. 1989. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl.Acad.Science, 86:6982-6986.
9. Behr, J.P. 1994. Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. Bioconj.Chem. 5:382-389.
10. Felgner P.L., Gadeck, T.R., Roman, M., Chan, H.W., Wenz, M., Ringold, G.M. and Danielsen, M. 1987. Lipofection: a highly efficient, lipid-mediated DNA transfection procedure. Proc.Natl.Acad.Science 84:7413-7417.
11. Zhu, N., Ligitt, D., Liu, Y. and Debs, R. 1993. Systemic gene expression after intravenous delivery into adult mice. Science 261:209-211.
12. Solodin, I., Brown, C., Bruno, M., Chow, C., Jang, E.H., Debs, R., and Heath, T. 1995. High efficiency in vivo gene delivery with novel series of amphiphilic imadazolium compounds. Biochemistry, 34:13537-13544.
13. Hofland, H.E., Shepard, L., and Sullivan, S.M. 1996. Formation of stable cationic lipid/DNA complexes for gene transfer. J.Biol.Chem. 93:7305-7309.
14. Plank, C., Mechtler, K., Szoka, F., and Wagner, E. 1996. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Human Gene Ther. 7:1441-1450.